Close icon

Ready to buy your
RightMed test?

GET STARTED >

The solution is here — in your DNA

Genetic factors can account for up to 95% of drug-response variability and susceptibility.3 In other words, how a drug will—or won't—work for a particular individual. Our RightMed® test brings pharmacogenomics to everyone, identifying how a patient's DNA and current medications may affect their response to drugs. OneOme: making prescriptions personal.

The OneOme RightMed solution is:

bullet_rigorous

RIGOROUS: Characterized by scientific and clinical data4,5

bullet_comprehensive

COMPREHENSIVE: Covers hundreds of medications for many medical conditions

bullet_interactive

INTERACTIVE: Includes the RightMed Advisor, an online clinical decision support tool for providers, which offers custom report options

bullet_credible

CREDIBLE: Co-developed and exclusively licensed with Mayo Clinic

bullet_accessible

ACCESSIBLE: Provided at a low-cost with multiple billing options available

bullet_supportive

SUPPORTIVE: Offers complementary consultations with clinical pharamcists, in addition to customer support

Healthcare of the future.
Available today.

Cost-effective, comprehensive, personalized pharmacogenomic analysis — integrated into patients' everyday clinical care.
OneOme helps healthcare providers choose the optimal drug therapy the first time, thanks to targeted and evidence-based inputs using each patient's DNA and current prescriptions.

While OneOme can help with any prescription decision, it's particularly meaningful for patients with:

  • oneome-brain
    psychiatric
    conditions
  • oneome-cancer-ribbon
    cancer
  • oneome-pain-symbol
    chronic
    pain
  • oneome-heart
    cardiology
  • oneome-cross
    more

Learn more about OneOme's products >

It's easy:
Swab. Send. Know.

swab.send.know



The physician-ordered OneOme RightMed comprehensive test identifies which prescription drugs are—or aren’t—likely to work based on your genetic makeup and current prescription interactions. OneOme generates a clear, actionable report to help your physicians to personalize your prescriptions.

The latest at OneOme

News

OneOme Expands its Comprehensive Pharmacogenomic Test Offering with New Genes and Medications

05/22/2018

MINNEAPOLIS (MAY 22, 2018) — OneOme, co-developed by Mayo Clinic, today announced several significant enhancements to its product offering, including the addition of four new genes (HLA-A, HLA-B, CYP4F2, and CYP2C Cluster) and nine new medications ...

READ MORE

Webinars & Events

2018 Angel & Eagles Golf Classic

07/23/2018

OneOme will be a sponsor at the 2018 Angel & Eagles Golf Classic, presented by Minnesota Oncology, on July 23, 2018 in Minneapolis, MN.

News

OneOme Named One of the World’s 50 Most Innovative Companies for 2018 by Fast Company

02/20/2018

MINNEAPOLIS (February 20, 2018) – OneOme, a healthcare technology company whose genetic test helps predict how a person will respond to hundreds of medications and enables healthcare providers to prescribe more effective medications, today announced that it is included in Fast Company’s annual ranking of the 50 Most Innovative Companies for 2018.

READ MORE

Webinars & Events

Webinar: Genetics and medication response — An introduction to pharmacogenomics

03/07/2018

In this webinar, we will:

  • provide an overview of pharmacogenomics and its potential
  • explain the impact of pharmacogenomics on the field of medicine
  • review the clinical validity of pharmacogenomics and some of the clinical guidelines available
  • introduce the OneOme RightMed® pharmacogenomic solution

READ MORE

News

Patients Can Now Request a OneOme RightMed® Test Through an Independent Provider Network

01/10/2018

MINNEAPOLIS (January 10, 2018) – Precision medicine company OneOme is partnering with PWNHealth to increase patient access to the RightMed® comprehensive test without compromising patient safety.

Until now, patients interested in the RightMed test could only get it by talking to their doctor. Th ...

READ MORE

Webinars & Events

MMGMA 2018 Summer Conference

07/25/2018

OneOme will be attending the 2018 MMGMA Summer Conference on July 25-27 in Duluth, MN.

  • fast company logo
  • minnpost logo
  • globe and mail logo

Select partners

Ridgeview Medical

“Before OneOme, only those with deep financial resources or the critically ill could access the power of pharmacogenomics. Today, patients at Ridgeview can receive personalized prescription insights that previously were inaccessible to them. Not only will our patients see better health outcomes – they are also avoiding life-threatening adverse drug reactions, which are the fourth leading cause of death.”

- Bob Stevens, President and CEO of Ridgeview Medical Center

oneome-circle-logo

Precision medicine. Informed care.